Trial Condition(s):

Hepatocellular carcinoma

Hepatocellular carcinoma registry for Turkey (3K Trial)

Bayer Identifier:

15807

ClinicalTrials.gov Identifier:

NCT01473121

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.

Inclusion Criteria
- To be diagnosed with hepatocellular carcinoma in last 3 months
 - To be older than 18 years old
 - To sign informed consent form (ICF)
Exclusion Criteria
- Patients that does not sign or withdraw informed consent form.
 - According to investigator’s opinion; existence of any situation/condition that will significantly complicate patient follow up.
 - Currently or previously taking part in 3K observational study

Trial Summary

Enrollment Goal
600
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Nexavar (Sorafenib, BAY43-9006)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Turkey

Status
Active, not recruiting
 

Trial Design